Inflammatory Bowel Disease

>

Latest News

FDA Approves Lilly’s Mirikizumab-mrkz for Crohn’s Disease ©MichaelVi/stock.adobe.com
FDA Approves Lilly’s Mirikizumab-mrkz for Crohn’s Disease

January 16th 2025

Marketed as Omvoh, the therapy is already approved as a first-in-class treatment for moderately to severely active ulcerative colitis.

January Issue of Patient Care Online Digital Edition is Now Live / Image credit: ©MJH Life Sciences
January Issue of Patient Care Online Digital Edition is Now Live

December 16th 2024

Intervention Cuts Alcohol Use in Youths with Chronic Medical Conditions: Daily Dose / image credit: ©New Africa/AdobeStock
Intervention Cuts Alcohol Use in Youths with Chronic Medical Conditions: Daily Dose

August 7th 2024

Disease-Tailored Preventive Intervention Reduces Alcohol Use in High-Risk Youths with Chronic Medical Conditions / Image credit: ©pressmaster/AdobeStock
Disease-Tailored Preventive Intervention Reduces Alcohol Use in High-Risk Youths with Chronic Medical Conditions

July 18th 2024

New Study Highlights Primary Drivers of Cost of Inflammatory Bowel Disease Care / Image credit: ©Crystal light/AdobeStock
New Study Highlights Primary Drivers of Cost of Inflammatory Bowel Disease Care

January 26th 2024

Video Series
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.